“…Excess catecholamines from reuptake inhibition in the CNS and peripheral circulation 4,17 a-Stimulation resulting in vasoconstriction 4,17,92,93,94 b-Stimulation resulting in tachycardia and increased risk of dysrhythmia 4,17,95 Blockade of sodium and potassium channels with increased risk of dysrhythmia 96 Increased risk of thrombosis from platelet activation 97 Increased intracellular calcium and increased risk of dysrhythmia 96,98 Inhibition of peripheral arterial baroreceptors with altered baroreflex [99][100][101][102] Acceleration of coronary arterial disease and enhanced vasoconstriction in diseased segments 92 Enhanced coronary microvascular disease 94,103 Additive vasoconstrictive effects in the presence of cigarette smoking 93 Generation of reactive oxygen and nitrogen species altering autoregulation of cardiac blood flow 104,105 Stimulation of the vasoconstrictor endothelin 106,107 Inhibition of NO production and associated vasodilation 106,107 Damage to coronary endothelium with increased sensitivity to vasoconstrictors 108 Direct cardiomyotoxicity from membrane oxidative damage and early apoptosis 104,105,109,110 Alteration of parasympathetic response with decreased heart rate variability 111,112 Abbreviations: CNS, central nervous system; NO, nitric oxide. potential unique adverse effects, and risk/benefit ratio must be taken into consideration by the prescribing clinician.…”